What is the current Liver Biopsy market size?

The Liver Biopsy market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Liver Biopsy market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What challenges does the Liver Biopsy market face?

High costs and risks associated with liver biopsy procedures are significant challenges.

Which regions are leading the Liver Biopsy market?

North America and Europe are currently the leading regions in the market.

Who are the top companies in the Liver Biopsy market?

Top companies include Medtronic, Boston Scientific, and Abbott Laboratories.

What future opportunities exist in the Liver Biopsy market?

Emerging markets and advancements in non-invasive biopsy technologies present future opportunities.

How is technology impacting the Liver Biopsy market?

Advances in imaging and diagnostic technologies are improving biopsy accuracy and efficiency.

What is the current regulatory landscape for the Liver Biopsy market?

Stringent regulations and guidelines are in place to ensure patient safety and product efficacy.

What is the future outlook for the Liver Biopsy market?

The future outlook is positive, driven by increasing demand for liver disease diagnosis and treatment.

Liver Biopsy Growth, Trends & Forecast Outlook 2033

Liver Biopsy by Application (Hospitals & Clinics, Diagnostic Centers, Others), by Types (Percutaneous, Transjugular, Laparoscopic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Liver Biopsy Market Size | CAGR 7.2 Forecast 2033

Liver Biopsy Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Liver Biopsy Market Overview

The Liver Biopsy market refers to the industry involved in the diagnosis and treatment of liver diseases through biopsy procedures. As a crucial diagnostic tool, the liver biopsy market size is estimated to be around $493.8 million in 2025. The growth outlook for the liver biopsy market forecast is promising, with a projected compound annual growth rate (CAGR) of 6.8% during the forecast period from 2026 to 2033. This industry expansion is driven by increasing prevalence of liver diseases, advancements in biopsy technologies, and rising demand for minimally invasive procedures. The scope of the liver biopsy market encompasses various types of biopsies, including percutaneous, transvenous, and laparoscopic, as well as different applications, such as diagnosis of liver cancer, hepatitis, and cirrhosis.

Loading chart…

The liver biopsy market is influenced by key forces such as technology shifts, regulatory requirements, and changing consumer behavior. The largest region in the liver biopsy market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and growing awareness of liver diseases. Macroeconomic drivers, including an aging population and rising healthcare costs, are also expected to impact the market. As the industry continues to evolve, it is essential for stakeholders to stay informed about the latest trends and developments shaping the liver biopsy market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cook Medical; Boston Scientific; Hologic; MDxHealth; CR Bard; Intact Medical; Veran Medical; Leica Biosystems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Liver Biopsy market is poised for significant growth, driven by increasing demand for diagnostic procedures and advancements in medical technology. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

Advances in liver biopsy techniques, such as percutaneous and transjugular approaches, have improved the accuracy and safety of procedures, contributing to the growth of the Liver Biopsy market size.

The rising prevalence of liver diseases, including non-alcoholic fatty liver disease and liver cancer, is fueling the demand for liver biopsies, driving the growth forecast of the Liver Biopsy market.

Restraints2 items

High costs associated with liver biopsy procedures and the need for specialized equipment and trained personnel are limiting the adoption of liver biopsies in some regions, affecting the overall Liver Biopsy market size.

The risk of complications, such as bleeding and infection, is a significant restraint to the growth of the Liver Biopsy market, as it can deter patients from undergoing the procedure.

Opportunities2 items

The increasing use of minimally invasive liver biopsy techniques is creating opportunities for the development of new products and services, driving innovation in the Liver Biopsy market.

The growing demand for liver biopsies in emerging economies presents opportunities for market players to expand their presence and increase their share of the Liver Biopsy market size.

Challenges2 items

The lack of standardization in liver biopsy procedures and the need for improved diagnostic accuracy are significant challenges facing the Liver Biopsy market, requiring continued investment in research and development.

The impact of macroeconomic factors, such as fluctuations in healthcare spending and reimbursement policies, can affect the growth forecast of the Liver Biopsy market, making it essential for stakeholders to monitor these trends closely.

Market Segmentation

Loading chart…

The Liver Biopsy market can be segmented based on Application, which includes diagnostic and research purposes. Diagnostic applications account for a significant share of the market, driven by the increasing prevalence of liver diseases such as hepatitis and liver cancer. The Liver Biopsy segmentation by application provides valuable insights into the market size and growth prospects of each segment.

The Liver Biopsy market can also be segmented based on Types, which include percutaneous, transvenous, and laparoscopic biopsies. Percutaneous biopsy is the most common type, accounting for a major share of the market. The market taxonomy of Liver Biopsy types helps to understand the market dynamics and trends, enabling stakeholders to make informed decisions.

Liver Biopsy Segmentation Breakdown8 items

Application

Hospitals & Clinics

Diagnostic Centers

Others

Types

Percutaneous

Transjugular

Laparoscopic

Regional Insights

Loading chart…

The Liver Biopsy market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The Asia Pacific region is anticipated to be the fastest-growing, driven by increasing adoption of advanced medical technologies, favorable government policies, and rising investments in healthcare infrastructure.

Key drivers for North America include high ecosystem maturity, significant investments in research and development, and a large patient population. In Europe, factors such as increasing adoption of minimally invasive procedures, favorable policies, and a well-established healthcare system contribute to the region's growth. The Asia Pacific region is driven by demographics, with a large and growing population, as well as increasing infrastructure development in countries such as China and India.

In Latin America, key drivers include growing investments in healthcare, increasing awareness about liver diseases, and improving infrastructure. The Middle East & Africa region is expected to be driven by government initiatives, rising adoption of advanced medical technologies, and growing demand for healthcare services. These regional forecast trends are expected to shape the Liver Biopsy market growth in the coming years.

Competitive Landscape

The Liver Biopsy market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. The Liver Biopsy competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and customization to cater to specific market needs.

Companies in the Liver Biopsy market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common competitive differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks, which necessitate continuous innovation and adaptation to remain competitive.

Cook Medical: regional expansion

Boston Scientific: innovation pipeline

Hologic: premium pricing

MDxHealth: OEM tie-ups

CR Bard: local manufacturing

Intact Medical: vertical integration

Key Liver Biopsy Companies8 items

Cook Medical

Boston Scientific

Hologic

MDxHealth

CR Bard

Intact Medical

Veran Medical

Leica Biosystems

Market Ecosystem

The Liver Biopsy ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. Value is created and captured through the development, manufacturing, and distribution of liver biopsy products and services, ultimately reaching hospitals, research institutions, and patients. This ecosystem can be broadly segmented into three tiers: upstream technology providers and suppliers, midstream integrators and channels, and downstream end users.

Raw material/component suppliers — providing biopsy needles and equipment

OEMs / manufacturers — producing liver biopsy devices

Technology providers — developing imaging and diagnostic technologies

System integrators / EPCs — integrating biopsy systems and equipment

Distributors / channel partners — supplying products to healthcare facilities

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing guidelines and approvals for biopsy products

In the Liver Biopsy ecosystem, control points are largely influenced by regulators and standards bodies, as well as technology providers and manufacturers. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the adoption of new products and services. Switching costs and partnerships between participants can also affect the ecosystem, particularly in terms of interoperability requirements and regional differences in healthcare infrastructure and regulations, highlighting the need for a thorough value chain analysis.

Recent Industry Insights

The Liver Biopsy market has witnessed significant developments over the last 12-18 months, shaping the future of Liver Biopsy industry trends. Recent partnerships, such as the collaboration between leading medical device manufacturers, have focused on improving biopsy needle technology. Mergers and acquisitions, like the takeover of a prominent biopsy equipment supplier, have also been notable. Furthermore, innovative product launches, including advanced imaging-guided biopsy systems, have enhanced the accuracy and safety of liver biopsy procedures.

Additionally, regulatory changes, including updated guidelines for biopsy sample handling and analysis, have been implemented to ensure patient safety and improve diagnosis accuracy. The Liver Biopsy industry trends are also being influenced by a shift towards minimally invasive procedures, driven by consumer demand for reduced recovery times and fewer complications. Funding rounds and expansions by key players in the market are expected to drive further innovation and growth in the Liver Biopsy sector.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Liver Biopsy market. The market attractiveness is moderate, driven by increasing liver disease prevalence and advancements in biopsy technologies. The competitive intensity is high, with key players investing in innovation and expansion. The long-term outlook for the Liver Biopsy market outlook is promising, with growing demand for minimally invasive procedures.

The innovation landscape is evolving, with a focus on improving diagnostic accuracy and patient comfort. However, the demand-supply balance is a key risk factor, as the market faces challenges in meeting the growing demand for skilled professionals and advanced equipment. Overall, the Liver Biopsy market is expected to experience steady growth, driven by technological advancements and increasing awareness of liver health.

11 items

1. Executive Summary

2. Liver Biopsy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Liver Biopsy Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Liver Biopsy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals & Clinics

6.1.2. Diagnostic Centers

6.1.3. Others

6.2. Global Liver Biopsy Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Percutaneous

6.2.2. Transjugular

6.2.3. Laparoscopic

6.3. Global Liver Biopsy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Liver Biopsy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Liver Biopsy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Liver Biopsy Market Competition by Key Manufacturers

8.1. Global Liver Biopsy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Liver Biopsy: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cook Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Hologic

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. MDxHealth

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. CR Bard

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Intact Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Veran Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Leica Biosystems

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Liver Biopsy Market

Figure 4: Global Liver Biopsy Market: Drivers

Figure 5: Global Liver Biopsy Market: Challenges

Figure 6: Global Liver Biopsy Market: Trends

Figure 7: Global Liver Biopsy Market: Opportunity

Figure 8: Global Liver Biopsy Market: Restraint

Figure 9: Global Liver Biopsy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Liver Biopsy Market Value (USD Million) By Region

Figure 15: Global Liver Biopsy Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Liver Biopsy Market Value (USD Million) By Region

Figure 23: Global Liver Biopsy Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Liver Biopsy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Liver Biopsy Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Liver Biopsy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Liver Biopsy Market Value (USD Million) By Region

Table 10: Global Liver Biopsy Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Liver Biopsy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Liver Biopsy Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Liver Biopsy Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cook Medical Basic Information And Sales Area

Table 31: Cook Medical. Products Portfolio

Table 32: Boston Scientific Basic Information And Sales Area

Table 33: Boston Scientific. Products Portfolio

Table 34: Hologic Basic Information And Sales Area

Table 35: Hologic. Products Portfolio

Table 36: MDxHealth Basic Information And Sales Area

Table 37: MDxHealth. Products Portfolio

Table 38: CR Bard Basic Information And Sales Area

Table 39: CR Bard. Products Portfolio

Table 40: Intact Medical Basic Information And Sales Area

Table 41: Intact Medical. Products Portfolio

Table 42: Veran Medical Basic Information And Sales Area

Table 43: Veran Medical. Products Portfolio

Table 44: Leica Biosystems Basic Information And Sales Area

Table 45: Leica Biosystems. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Liver Biopsy Market Value (USD Million) By Region

Table 51: Global Liver Biopsy Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Liver Biopsy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cook Medical; Boston Scientific; Hologic; MDxHealth; CR Bard; Intact Medical; Veran Medical; Leica Biosystems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options